Formycon AG

Formycon AGverified

FYB.DE

Price:

$23.9

Market Cap:

$422.18M

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also develo...[Read more]

Industry

Biotechnology

IPO Date

2011-01-04

Stock Exchange

XETRA

Ticker

FYB.DE

The Enterprise Value as of December 2025 (TTM) for Formycon AG (FYB.DE) is 405.11M

According to Formycon AG’s latest financial reports and current stock price. The company's current Enterprise Value is 405.11M. This represents a change of -49.22% compared to the average of 797.81M of the last 4 quarters.

Formycon AG (FYB.DE) Historical Enterprise Value (quarterly & annually)

How has FYB.DE Enterprise Value performed in the past?

The mean historical Enterprise Value of Formycon AG over the last ten years is 546.94M. The current 405.11M Enterprise Value has changed 7.31% with respect to the historical average. Over the past ten years (40 quarters), FYB.DE's Enterprise Value was at its highest in in the December 2022 quarter at 1.35B. The Enterprise Value was at its lowest in in the January 2009 quarter at 0.

Quarterly (TTM)
Annual

Average

546.94M

Median

424.10M

Minimum

214.39M

Maximum

1.23B

Formycon AG (FYB.DE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Formycon AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 136.21%

Maximum Annual Enterprise Value = 1.23B

Minimum Annual Increase = -26.57%

Minimum Annual Enterprise Value = 214.39M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024897.57M-0.28%
2023900.10M-26.57%
20221.23B94.04%
2021631.77M15.51%
2020546.96M84.23%
2019296.88M23.94%
2018239.54M-20.48%
2017301.24M40.51%
2016214.39M-0.33%
2015215.11M136.21%

Formycon AG (FYB.DE) Average Enterprise Value

How has FYB.DE Enterprise Value performed in the past?

The current Enterprise Value of Formycon AG (FYB.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.01B

5-year avg

840.45M

10-year avg

546.94M

Formycon AG (FYB.DE) Enterprise Value vs. Peers

How is FYB.DE’s Enterprise Value compared to its peers?

Formycon AG’s Enterprise Value is less than Verastem, Inc. (502.77M), greater than Zura Bio Limited (122.37M), less than Medios AG (452.48M), greater than Stratec SE (378.04M), greater than Heidelberg Pharma AG (111.07M), less than Newron Pharmaceuticals S.p.A. (455.39M), greater than 4basebio PLC (94.62M), greater than BRAIN Biotech AG (55.67M), greater than M1 Kliniken AG (304.21M), greater than High Tide Inc. (365.89M),

CompanyEnterprise ValueMarket cap
502.77M$493.39M
122.37M$221.07M
452.48M$347.90M
378.04M$268.04M
111.07M$133.80M
455.39M$433.15M
94.62M$123.10M
55.67M$66.20M
304.21M$327.87M
365.89M$217.78M

Build a custom stock screener for Formycon AG (FYB.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Formycon AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Formycon AG (FYB.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Formycon AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Formycon AG's Enterprise Value?

What is the highest Enterprise Value for Formycon AG (FYB.DE)?

What is the 3-year average Enterprise Value for Formycon AG (FYB.DE)?

What is the 5-year average Enterprise Value for Formycon AG (FYB.DE)?

How does the current Enterprise Value for Formycon AG (FYB.DE) compare to its historical average?